Rentschler Biopharma Announces Major Investment in Germany
24 Oct 2024 //
GLOBENEWSWIRE
Rentschler Biopharma Gets ISO 27001 For Information Security
30 Sep 2024 //
PRESS RELEASE
Rentschler Biopharma Launches New LVV Mfg. Toolbox for ATMPs
03 Sep 2024 //
CONTRACT PHARMA
CDMO Rentschler Expands Production With New MA Facility Line
12 Jul 2024 //
FIERCE PHARMA
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts
11 Jul 2024 //
PRESS RELEASE
Rentschler Biopharma`s New Production Line In Massachusetts Now Operating
11 Jul 2024 //
GLOBENEWSWIRE
Rentschler Names Patrick Meyer as Global Head BD Sales & Alliance Management
28 May 2024 //
PRESS RELEASE
Rentschler Biopharma Names Dr. Patrick Cushing as VP, Operations in U.S.
02 May 2024 //
PRESS RELEASE
Rentschler Takes Home the Gold in 20th Annual Team Economic Impact Awards
13 Mar 2024 //
GLOBENEWSWIRE
Rentschler contributes to nearly 25% of biopharmaceuticals in 2023
06 Mar 2024 //
GLOBENEWSWIRE
Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions
06 Feb 2024 //
GLOBENEWSWIRE
Charles River to make Casgevy; Rentschler extends collab with ‘major client
21 Dec 2023 //
ENDPTS
Rentschler Biop Announces Major Client Project for New U.S. Facility at MA Site
20 Dec 2023 //
GLOBENEWSWIRE
Rentschler appoints Gunnar Voss von Dahlen as Chief Financial Officer
07 Dec 2023 //
GLOBENEWSWIRE
Rentschler Names Industry Veterans to Leadership Posts
19 Sep 2023 //
CONTRACT PHARMA
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer
19 Sep 2023 //
GLOBENEWSWIRE
Rentschler Biopharma Names Head of Clinical and Commercial Mfg.
12 Jul 2023 //
CONTRACT PHARMA
Rentschler Biopharma, Ikarovec Partner on Gene Therapies for Ophthalmic Disease
01 Jun 2023 //
CONTRACT PHARMA
Rentschler supports the Laupheim Planetarium with a donation of 25,000 Euros
15 May 2023 //
PRESS RELEASE
FDA cites quality issues at Rentschler and Eli Lilly facilities
04 May 2023 //
ENDPTS
FDA Issues Form 483 to Rentschler Biopharma
03 May 2023 //
FDA
Rentschler Biopharma Receives Worcester Business Journal 2023
27 Apr 2023 //
GLOBENEWSWIRE
Rentschler Biopharma Appoints Global Head Digital Mfg. and Automation
12 Apr 2023 //
CONTRACT PHARMA
Rentschler service excellence recognized with CDMO Leadership Awards
20 Mar 2023 //
GLOBENEWSWIRE
Rentschler Biopharma Celebrates 150th Anniversary
07 Dec 2022 //
CONTRACTPHARMA
Rentschler and Oxford are the latest companies swapping out CEOs
22 Nov 2022 //
FIERCEPHARMA
Rentschler Biopharma - Dr. Frank Mathias to return to the Supervisory Board
21 Nov 2022 //
GLOBENEWSWIRE
Rentschler Biopharma Appoints Christiane Bardroff as COO
16 Nov 2022 //
CONTRACTPHARMA
Rentschler Biopharma Taps Tobias Glueck as SVP Human Relations
14 Oct 2022 //
CONTRACTPHARMA
Rentschler Biopharma Appoints Mark Caswell as VP, Site Head
18 Aug 2022 //
CONTRACTPHARMA
Rentschler Biopharma Expands Leadership Team
10 Aug 2022 //
MANUFACTURINGCHEMIST
Rentschler Biopharma Expands Leadership Team
10 Aug 2022 //
MANUFACTURING CHEMIST
German manufacturer hit with Form 483 for multiple production issues
14 Jun 2022 //
ENDPTS
Rentschler Biopharma adds executive to team; provides update on progress
13 Jun 2022 //
GLOBENEWSWIRE
FDA Issues form 483 to Rentschler Biopharma SE
11 Jun 2022 //
FDA
Rentschler Bio and Vetter Unveil Xpert Alliance, Enter Strategic Collaboration
29 Mar 2022 //
BUSINESSWIRE
Rentschler Biopharma and Vetter Unveil Xpert Alliance
29 Mar 2022 //
CONTRACTPHARMA
Rentschler Biopharma reports strong growth and continues hiring at all
20 Dec 2021 //
GLOBENEWSWIRE
Robert Panting Appointed GM of Rentschler ATMP CoE
28 Oct 2021 //
CONTRACTPHARMA
Rentschler Biopharma, XL-Protein Enter Manufacturing Pact
26 Oct 2021 //
CONTRACTPHARMA
Rentschler Biopharma Partners with SPI to Expand Japanese Operations
04 Oct 2021 //
PHARMTECH
Rentschler Biopharma donates 50,000 Euros to support construction
22 Sep 2021 //
GLOBENEWSWIRE
Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer
20 Sep 2021 //
GLOBENEWSWIRE
Rentschler Biopharma Appoints Dr. Christian Schetter as CSO
20 Sep 2021 //
CONTRACTPHARMA
CureVac slashes COVID-19 vaccine production plans
15 Sep 2021 //
REUTERS
Rentschler ready to start commercial production of CureVac COVID-19 shot
19 Aug 2021 //
REUTERS
Rentschler Biopharma Breaks Ground at U.S. Site Near Boston
11 Aug 2021 //
CONTRACT PHARMA
Rentschler Expands Complex Antibodies Production in Germany
30 Jun 2021 //
CONTRACTPHARMA
Vetter, Rentschler Biopharma Advance Strategic Alliance
30 Apr 2021 //
CONTRACTPHARMA
Rentschler Biopharma Names Martin Kessler as New CEO in U.S.
31 Mar 2021 //
CONTRACTPHARMA
Rentschler, Leukocare Extend Service Offering with U.S. Site
22 Mar 2021 //
CONTRACTPHARMA
Rentschler Biopharma Establishes Cell and Gene CoE
11 Feb 2021 //
CONTRACTPHARMA
CureVac, Rentschler Ramp up COVID Vax Production
01 Feb 2021 //
CONTRACTPHARMA
Rentschler Biopharma and ATUM Ink Licensing Agreement
15 Oct 2020 //
CONTRACTPHARMA
Rentschler Biopharma to provide cGMP MFG services for BioNTech & Pfizer’s Mrna
09 Oct 2020 //
PHARMABIZ
Joining forces against SARS-CoV-2: Rentschler Biopharma contributes to MFG
08 Oct 2020 //
THE ARABIAN POST
Vetter and Rentschler Team Up for Strategic Collaboration
06 Jul 2020 //
PHARMTECH
Rentschler Biopharma Extends Collaboration with Genmab to U.S. facility
27 May 2020 //
GLOBENEWSWIRE
Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform
19 May 2020 //
BUSINESSWIRE
Rentschler Kicks Off Expansion at U.S. Facility
11 Nov 2019 //
CONTRACTPHARMA